These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 9110103

  • 21. Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans.
    Mueller EA, Murphy DL, Sunderland T.
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1179-84. PubMed ID: 4055985
    [Abstract] [Full Text] [Related]

  • 22. The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia.
    Scheepers FE, Gespen de Wied CC, Kahn RS.
    J Clin Psychopharmacol; 2001 Dec; 21(6):575-82. PubMed ID: 11763004
    [Abstract] [Full Text] [Related]

  • 23. Hormonal and subjective responses to intravenous meta-chlorophenylpiperazine in bulimia nervosa.
    Levitan RD, Kaplan AS, Joffe RT, Levitt AJ, Brown GM.
    Arch Gen Psychiatry; 1997 Jun; 54(6):521-7. PubMed ID: 9193192
    [Abstract] [Full Text] [Related]

  • 24. Daily administration of m-chlorophenylpiperazine to healthy human volunteers rapidly attenuates many of its behavioral, hormonal, cardiovascular and temperature effects.
    Benjamin J, Greenberg BD, Murphy DL.
    Psychopharmacology (Berl); 1996 Sep; 127(2):140-9. PubMed ID: 8888380
    [Abstract] [Full Text] [Related]

  • 25. Behavioral and neuroendocrine responses to metaCPP in anorexia nervosa.
    Hadigan CM, Walsh BT, Buttinger C, Hollander E.
    Biol Psychiatry; 1995 Apr 15; 37(8):504-11. PubMed ID: 7619973
    [Abstract] [Full Text] [Related]

  • 26. Gender-dependent dissociation between oxytocin but not ACTH, cortisol or TSH responses to m-chlorophenylpiperazine in healthy subjects.
    Bagdy G, Arato M.
    Psychopharmacology (Berl); 1998 Apr 15; 136(4):342-8. PubMed ID: 9600579
    [Abstract] [Full Text] [Related]

  • 27. Serotonin hypothesis of winter depression: behavioral and neuroendocrine effects of the 5-HT(1A) receptor partial agonist ipsapirone in patients with seasonal affective disorder and healthy control subjects.
    Schwartz PJ, Turner EH, Garcia-Borreguero D, Sedway J, Vetticad RG, Wehr TA, Murphy DL, Rosenthal NE.
    Psychiatry Res; 1999 Apr 19; 86(1):9-28. PubMed ID: 10359479
    [Abstract] [Full Text] [Related]

  • 28. Headache and cortisol responses to m-chlorophenylpiperazine are highly correlated.
    Gordon ML, Lipton RB, Brown SL, Nakraseive C, Russell M, Pollack SZ, Korn ML, Merriam A, Solomon S, van Praag HM.
    Cephalalgia; 1993 Dec 19; 13(6):400-5. PubMed ID: 8313453
    [Abstract] [Full Text] [Related]

  • 29. Alterations in 8-hydroxy-2-(dipropylamino)tetralin-induced neuroendocrine responses after 5,7-dihydroxytryptamine-induced denervation of serotonergic neurons.
    Van de Kar LD, Li Q, Cabrera TM, Brownfield MS, Battaglia G.
    J Pharmacol Exp Ther; 1998 Jul 19; 286(1):256-62. PubMed ID: 9655867
    [Abstract] [Full Text] [Related]

  • 30. Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects.
    Kahn RS, Wetzler S, Asnis GM, Kling MA, Suckow RF, van Praag HM.
    Psychiatry Res; 1991 Apr 19; 37(1):25-34. PubMed ID: 1650487
    [Abstract] [Full Text] [Related]

  • 31. The effects of sub-chronic administration of hydrocortisone on hormonal and psychological responses to L-tryptophan in normal male volunteers.
    Porter RJ, Gallagher P, Watson S, Lunn BS, Young AH.
    Psychopharmacology (Berl); 2002 Aug 19; 163(1):68-75. PubMed ID: 12185402
    [Abstract] [Full Text] [Related]

  • 32. Serotonin1A receptor activation by flesinoxan in humans. Body temperature and neuroendocrine responses.
    Seletti B, Benkelfat C, Blier P, Annable L, Gilbert F, de Montigny C.
    Neuropsychopharmacology; 1995 Oct 19; 13(2):93-104. PubMed ID: 8597527
    [Abstract] [Full Text] [Related]

  • 33. Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects.
    Broocks A, Meyer T, Gleiter CH, Hillmer-Vogel U, George A, Bartmann U, Bandelow B.
    Psychopharmacology (Berl); 2001 May 19; 155(3):234-41. PubMed ID: 11432685
    [Abstract] [Full Text] [Related]

  • 34. 5-Hydroxytryptamine 1A receptors, major depression, and suicidal behavior.
    Pitchot W, Hansenne M, Pinto E, Reggers J, Fuchs S, Ansseau M.
    Biol Psychiatry; 2005 Dec 01; 58(11):854-8. PubMed ID: 16139805
    [Abstract] [Full Text] [Related]

  • 35. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers.
    Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, Gorman JM, Klein DF, Liebowitz MR.
    Arch Gen Psychiatry; 1992 Jan 01; 49(1):21-8. PubMed ID: 1728249
    [Abstract] [Full Text] [Related]

  • 36. Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia.
    Brewerton TD, Mueller EA, Lesem MD, Brandt HA, Quearry B, George DT, Murphy DL, Jimerson DC.
    Arch Gen Psychiatry; 1992 Nov 01; 49(11):852-61. PubMed ID: 1444722
    [Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics and CNS pharmacodynamics of the 5-HT1A agonist buspirone in humans following acute L-tryptophan depletion challenge.
    Jagannathan V, Venitz J.
    Methods Find Exp Clin Pharmacol; 1997 Jun 01; 19(5):351-62. PubMed ID: 9379784
    [Abstract] [Full Text] [Related]

  • 38. The psychobiology of burnout: are there two different syndromes?
    Tops M, Boksem MA, Wijers AA, van Duinen H, Den Boer JA, Meijman TF, Korf J.
    Neuropsychobiology; 2007 Jun 01; 55(3-4):143-50. PubMed ID: 17641533
    [Abstract] [Full Text] [Related]

  • 39. Pindolol does not augment cortisol and prolactin responses to paroxetine in healthy subjects.
    Brunswick DJ, Goodman DB, O'Reardon JP, Chopra M, Amsterdam JD.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May 01; 28(3):477-80. PubMed ID: 15093954
    [Abstract] [Full Text] [Related]

  • 40. Serotonin dysfunction in pathological gamblers: increased prolactin response to oral m-CPP versus placebo.
    Pallanti S, Bernardi S, Quercioli L, DeCaria C, Hollander E.
    CNS Spectr; 2006 Dec 01; 11(12):956-64. PubMed ID: 17146409
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.